SG Americas Securities’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.2M | Buy |
296,339
+8,137
| +3% | +$356K | 0.02% | 670 |
|
|
2025
Q4 | $11.1M | Buy |
288,202
+234,629
| +438% | +$8.95M | 0.01% | 724 |
|
|
2025
Q3 | $1.89M | Sell |
53,573
-15,132
| -22% | -$548K | 0.01% | 981 |
|
|
2025
Q2 | $2.48M | Buy |
68,705
+15,218
| +28% | +$504K | 0.01% | 687 |
|
|
2025
Q1 | $1.67M | Buy |
+53,487
| New | +$1.7M | 0.01% | 870 |
|
|
2024
Q4 | – | Sell |
-62,131
| Closed | -$1.76M | – | 3545 |
|
|
2024
Q3 | $1.76M | Buy |
62,131
+53,008
| +581% | +$1.47M | 0.01% | 735 |
|
|
2024
Q2 | $241K | Sell |
9,123
-88,380
| -91% | -$2.45M | ﹤0.01% | 2080 |
|
|
2024
Q1 | $2.96M | Buy |
+97,503
| New | +$2.87M | 0.02% | 735 |
|
|
2023
Q4 | – | Sell |
-5,300
| Closed | -$144K | – | 3394 |
|
|
2023
Q3 | $144K | Sell |
5,300
-18,344
| -78% | -$545K | ﹤0.01% | 2531 |
|
|
2023
Q2 | $727K | Buy |
23,644
+11,910
| +101% | +$403K | 0.01% | 1218 |
|
|
2023
Q1 | $423K | Buy |
+11,734
| New | +$435K | 0.01% | 1847 |
|
|
2022
Q4 | – | Sell |
-16,437
| Closed | -$660K | – | 3340 |
|
|
2022
Q3 | $660K | Sell |
16,437
-3,114
| -16% | -$133K | 0.01% | 1301 |
|
|
2022
Q2 | $822K | Buy |
19,551
+1,455
| +8% | +$59.6K | 0.01% | 1477 |
|
|
2022
Q1 | $705K | Buy |
+18,096
| New | +$711K | 0.01% | 1663 |
|
|
2021
Q4 | – | Sell |
-25,983
| Closed | -$939K | – | 3757 |
|
|
2021
Q3 | $939K | Buy |
25,983
+14,509
| +126% | +$564K | 0.01% | 1968 |
|
|
2021
Q2 | $470K | Sell |
11,474
-22,925
| -67% | -$975K | ﹤0.01% | 1970 |
|
|
2021
Q1 | $1.5M | Buy |
34,399
+21,305
| +163% | +$1.01M | 0.01% | 1250 |
|
|
2020
Q4 | $655K | Buy |
+13,094
| New | +$556K | ﹤0.01% | 1784 |
|
Other funds holding RPRX
